Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pituitary adenomas

D W Andrews1

  • 1Thomas Jefferson University, Department of Neurosurgery, Philadelphia, PA 19486, USA.

Current Opinion in Oncology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

This review covers recent advancements in treating pituitary adenomas. It examines surgical, medical, and radiation therapies, including stereotactic radiosurgery, for optimal patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple partners can kiss-and-run: Bax transfers between multiple membranes and permeabilizes those primed by tBid.

Cell death & disease·2014
Same author

The apoptotic pore on mitochondria: are we breaking through or still stuck?

Cell death and differentiation·2014
Same author

Still embedded together binding to membranes regulates Bcl-2 protein interactions.

Oncogene·2010
Same author

Bid: a Bax-like BH3 protein.

Oncogene·2009
Same author

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.

Cell death and differentiation·2009
Same author

Fractionated stereotactic radiotherapy for parasellar meningiomas: a preliminary report of visual outcomes.

The British journal of ophthalmology·2005
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Endocrinology
  • Oncology

Background:

  • Pituitary adenomas are common tumors affecting hormone regulation.
  • Effective treatment is crucial for managing associated endocrinopathies and mass effects.

Purpose of the Study:

  • To review recent developments in pituitary adenoma treatment modalities.
  • To provide an overview of current surgical, medical, and radiation-based interventions.

Main Methods:

  • Comprehensive literature review of recent advancements.
  • Analysis of transcranial and transsphenoidal surgical techniques.
  • Evaluation of medical therapies for endocrinopathies.
  • Assessment of conventional radiation and stereotactic radiosurgery.

Related Experiment Videos

Main Results:

  • Surgical options remain a primary treatment for many pituitary adenomas.
  • Medical management is essential for hormone-related complications.
  • Radiation therapy, including stereotactic radiosurgery, offers targeted treatment options.

Conclusions:

  • Multimodal treatment strategies are key for managing pituitary adenomas.
  • Ongoing research continues to refine therapeutic approaches.
  • Personalized treatment plans improve patient prognosis and quality of life.